Clinuvel Pharmaceuticals reported AUD50.2M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesoblast USD 1.29B 8.58M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025